Found 4 matching trials
Anti-FLT3 CAR T-cell Therapy in FLT3 Positive Relapsed/Refractory Acute Myeloid Leukemia PHASE1 This is a prospective,open-label, phase1/2 study to evaluate the safety and...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML PHASE1 This is a phase 1 dose escalation study to determine the safety of anti-FLT...
Show More Learn More & Join Trial
Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia PHASE1 This is a clinical trial of Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in ...
Show More Location
Wuhan Union Hospital
Learn More & Join Trial
Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia EARLY_PHASE1 This study is a single-arm, open-label, dose-escalating trial to explore th...
Show More Location
First Affiliated Hospital of Soochow University
Learn More & Join Trial